Study Comparing the Safety and Efficacy of BOL-303259-X to Latanoprost in Subjects With Glaucoma or Ocular Hypertension

NCT01223378 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

413

Enrollment

INDUSTRY

Sponsor class

Conditions

Intraocular Pressure

Interventions

DRUG: BOL-303259-X
DRUG: Latanoprost

Sponsor

Bausch & Lomb Incorporated